Pharmicell (Korea) Performance
| 005690 Stock | 9,080 50.00 0.55% |
Pharmicell holds a performance score of 21 on a scale of zero to a hundred. The company holds a Beta of -0.53, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Pharmicell are expected to decrease at a much lower rate. During the bear market, Pharmicell is likely to outperform the market. Use Pharmicell market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to analyze future returns on Pharmicell.
Risk-Adjusted Performance
21 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmicell are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Pharmicell sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 20.9 B |
Pharmicell |
Pharmicell Relative Risk vs. Return Landscape
If you would invest 498,000 in Pharmicell on October 26, 2024 and sell it today you would earn a total of 410,000 from holding Pharmicell or generate 82.33% return on investment over 90 days. Pharmicell is generating 1.0467% of daily returns and assumes 3.9238% volatility on return distribution over the 90 days horizon. Simply put, 34% of stocks are less volatile than Pharmicell, and 80% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Pharmicell Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmicell's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Pharmicell, and traders can use it to determine the average amount a Pharmicell's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2668
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 005690 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.92 actual daily | 34 66% of assets are more volatile |
Expected Return
| 1.05 actual daily | 20 80% of assets have higher returns |
Risk-Adjusted Return
| 0.27 actual daily | 21 79% of assets perform better |
Based on monthly moving average Pharmicell is performing at about 21% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharmicell by adding it to a well-diversified portfolio.
Pharmicell Fundamentals Growth
Pharmicell Stock prices reflect investors' perceptions of the future prospects and financial health of Pharmicell, and Pharmicell fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pharmicell Stock performance.
| Return On Equity | -0.29 | |||
| Return On Asset | -0.0498 | |||
| Profit Margin | (1.12) % | |||
| Operating Margin | (0.39) % | |||
| Current Valuation | 660.29 B | |||
| Shares Outstanding | 60 M | |||
| Price To Book | 8.11 X | |||
| Price To Sales | 29.95 X | |||
| Revenue | 50.89 B | |||
| EBITDA | 12.93 B | |||
| Cash Flow From Operations | (5.22 B) | |||
| Total Asset | 95.81 B | |||
About Pharmicell Performance
By analyzing Pharmicell's fundamental ratios, stakeholders can gain valuable insights into Pharmicell's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pharmicell has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pharmicell has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Pharmicell performance evaluation
Checking the ongoing alerts about Pharmicell for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pharmicell help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pharmicell appears to be risky and price may revert if volatility continues | |
| Pharmicell generates negative cash flow from operations |
- Analyzing Pharmicell's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharmicell's stock is overvalued or undervalued compared to its peers.
- Examining Pharmicell's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pharmicell's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharmicell's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pharmicell's stock. These opinions can provide insight into Pharmicell's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Pharmicell Stock analysis
When running Pharmicell's price analysis, check to measure Pharmicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmicell is operating at the current time. Most of Pharmicell's value examination focuses on studying past and present price action to predict the probability of Pharmicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmicell's price. Additionally, you may evaluate how the addition of Pharmicell to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |